CA
Capricor Therapeutics, Inc.
CAPR · NASDAQ
$9.06 -2.53% (-$0.23)
1M +37.72%
Market Cap $541.8M
P/E Ratio -
Div. Yield -
ROE 56.60%
Bulios Fair Price
$5.62
38.0% downside
Trenutna cena
$9.06
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CAPR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
95 /100
Cheap P/B 2.20x
EV/EBITDA 0.52x
PEG N/A
Growth
100 /100
Growing Book val. growth 196.04%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 35.10%
ROIC 40.08%
Debt
78 /100
Low Net debt/EBITDA 0.06x
Int. coverage -41.49x
Debt/Equity 0.37x
Stability
28 /100
Unstable Profitable years 0
EPS volatility 63.16%
Beta 0.53x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CAPR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Linda Marbán
Employees
231
Headquarters
San Diego
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report